Interferon-gamma (INFG), an important marker of response to immune checkpoint blockade (ICB) in non-small cell lung cancer (NSCLC) and melanoma patients.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Niki Karachaliou, Guillermo Crespo, Erika Aldeguer, Ana Drozdowskyj, Ana Gimenez Capitan, Cristina Teixido, Miguel Angel Molina-Vila, Santiago Viteri Ramirez, Daniela Morales-Espinosa, Maria de los Llanos Gil, Maria Gonzalez-Cao, Salvador Martin Algarra, Elisabeth Pérez-Ruiz, Ivan Marquez Rodas, Delvys Rodriguez-Abreu, Remei Blanco, Teresa Puertolas, Maria Angeles Royo, Rafael Rosell
Institutions: Hospital Universitari Sagrat Cor, Hospital Universitario de Burgos, Pivotal (Spain), Hospital Universitario Dexeus, Clinica Universidad de Navarra, Hospital Costa del Sol, Hospital General Universitario Gregorio Marañón, Hospital Universitario Insular de Gran Canaria, Consorci Sanitari de Terrassa, Hospital Universitario Miguel Servet, Hospital Universitario Doctor Peset, Institut Català d'Oncologia
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2762461685